NCT06807788View on ClinicalTrials.gov

Evaluation of Platelet Aggregability in Patients with Takayasu's Arteritis

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 14, 2024

Primary Completion Date

October 14, 2026

Study Completion Date

October 14, 2027

Conditions
Takayasu Arteritis (TAK)Vasculitis, Systemic
Interventions
DRUG

Clopidogrel

Clopidogrel 75 mg once a day for 14 days.

Trial Locations (1)

Unknown

Heart Institute (InCor) / University of São Paulo, São Paulo, São Paulo

All Listed Sponsors
lead

Jose Carlos Nicolau

OTHER

NCT06807788 - Evaluation of Platelet Aggregability in Patients with Takayasu's Arteritis | Biotech Hunter | Biotech Hunter